Data / Form D filings / Cadenza Bio, Inc.
Cadenza Bio, Inc.: Form D filing
Cadenza Bio, Inc., a biotechnology company in Yukon, OK, filed a Form D with the SEC in 2025. The latest, on August 28, 2025, reports $2.4 million sold of a $2.4 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 14504 CHAMBORD DRIVE, Yukon, OK, 73099
- Phone
- (217) 649-5294
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2083534
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | New notice | $2,440,000 | $2,440,000 | 10 | Dec 4, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elaine Hamm | Executive Officer, Director | |
| Tom Denison | Director | |
| Carol Curtis | Executive Officer, Director |
Other biotechnology companies in Oklahoma that filed recently
- Endless Corp $100,000 · Aug 19, 2026
Every Form D from the week of Aug 25, 2025 · All recent filings in Oklahoma · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cadenza Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.